SITC Archive Library

Presentation slides and video from the 2020 Advances in Cancer Immunotherapy^TM - Charleston, SC, held on February 1, 2020 are available here.

Program Organizers

• David M. Neskey, MD – MUSC Hollings Cancer Center
• Chrystal M. Paulos, PhD – Medical University of South Carolina
• Jessica Thaxton, PhD, MSCR – Medical University of South Carolina

Program Summary

Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these programs will facilitate understanding of:

• The rationale for common approaches to immunotherapy
• The appropriate clinical management of common side effects of immunotherapy agents
• Implementing appropriate cancer immunotherapy treatments for skin, lung, genitourinary, head and neck, hematologic and/or additional solid tumor cancers in clinical practice
• Overcoming operational and financial barriers to integrating cancer immunotherapy into their practice setting
• Appropriate implementation of cancer care counsel in the clinical setting

Note: Concurrent sessions "Immunotherapy for the Treatment of Lung Cancer" presented by John M. Wrangle, MD, "Immunotherapy for the Treatment of Genitourinary Cancers" presented by Theodore Gourdin, MD, and "Immunotherapy for the Treatment of Additional Solid Tumors: Breast Cancer" presented by Antonio Giordano, MD, PhD were not recorded. Please reference recordings from other ACI programs by clicking here.

#Biomarkers#ClinicalTrials#MonoclonalAntibodies#Tumormutationalburden(TMB)
#BladderCancer#BreastCancers#GastrointestinalCancers#GenitourinaryCancers
#GynecologicCancers#HeadandNeckCancers#HematologicMalignancies#Leukemia
#LungCancers#Lymphoma#Melanoma#MerkelCellCarcinoma#NonSmallCellLungCancer
#ProstateCancer#RenalCellCarcinoma#SkinCancers#SmallCellLungCancer#LiverCancer
#AdoptiveCellTherapy#AntibodyDrugConjugates#BispecificAntibodies#CombinationTherapy
#Cytokines#ImmuneCheckpointInhibitors#OncolyticViruses#Vaccines#AdverseEvents
#SideEffects#Toxicities#CoverageandReimbursement#HospitalOperations#InPersonEvent
#PresentationSlides#Video#AdvancesinCancerImmunotherapy(ACI)#AlliedHealth#Clinician
#EmergencyPhysician#Industry#NursePractitioner#Oncologist#PrimaryCarePhysician
#Pharmacist#Physician#RegisteredNurse#2020